Cannabis compound slows artery disease in mice

	Tweet

An active ingredient in cannabis can ease inflammation and slow the progression of coronary artery disease in mice, and possibly humans, researchers said on Wednesday.

Daily low doses of the ingredient, THC, prevented atherosclerosis, a primary cause of heart disease and Stroke in western countries, without producing the associated high.

"We have proven that very low doses of cannabis therapy will have an anti-inflammatory effect that will slow the progression of Atherosclerosis in mice,” said Dr Francois Mach, of Geneva University Hospital in Switzerland.

He and his team do not know whether TCH, or delta-9-tetrahydrocannabinol, will have the same effect in humans. But they believe the discovery will help find compounds that produce the same effect in humans without side effects such as raised blood pressure or euphoria.

“The goal now is to find new molecules, new compounds, that will act only on this anti-inflammatory effect,” Mach told Reuters. Atherosclerosis is a common disorder of the arteries, in which fatty materials build up and eventually block the arteries and interfere with blood flow.

THC and similar molecules are known as cannabinoids. Cannabis, which contains more than 60 different cannabinoids, and hashish have been used for centuries for medicinal purposes.

Mach and his team gave mice that were genetically engineered to be prone to Atherosclerosis very low oral doses of THC with food each day. The dose was about 10 times less than that from smoking cannabis.

“It is the first study showing any beneficial effect of cannabis therapy on Atherosclerosis,” said Mach.

Cannabis creates a high when it binds to receptors called CB1 on the surface of cells in the brain. In the mouse study, another receptor, CB2, which is found on immune system cells and has nothing to do with euphoria, was affected. The dose given to the mice was too low to create a sense of euphoria.

Mice given THC had a slower progression of the disease than other mice not given the compound. The scientists are now studying whether THC can prevent the illness in the rodents.

“We are planning to look in more detail into how cannabis interferes with inflammation,” said Mach.

“What we have proven in mice is that acting on this receptor 2 ... has an anti-inflammatory effect that is very beneficial against the development of Atherosclerosis.”

In a commentary on the research in Nature magazine, Michael Roth, of the University of California in Los Angeles, described the findings as striking.

“But they should not be taken to mean that smoking marijuana is beneficial for the heart,” he said.

On the contrary, it increases the pulse rate and causes sharp rises and then falls in blood pressure upon standing and walking.

The Netherlands was the world’s first country to make cannabis available as a prescription drug for cancer, HIV and multiple sclerosis (MS). In the United States it is used to treat weight loss in AIDS patients and nausea and vomiting in cancer sufferers.

In Britain, GW Pharmaceuticals Plc has been pioneering cannabis-based medicine. 

RELATED STORIES:
U.S. FDA restricts tobacco marketing to kids   Evidence Backs Web- and Computer-Based Stop-Smoking Programs   Smoking Hits New Low for White California Kids   Study examines use of opioids   Racial and ethnic differences in nicotine metabolism exist among adolescent smokers   Anti-Cigarette Ads Up In Smoke?   Prenatal exposure to tobacco smoke raises blood pressure in infants   More girls than boys trying drugs for first time   New study demonstrates nicotine’s role in smoking behavior   Message on a bottle - Heineken backs drink restraint   Marijuana use on the rise among Ontario adults, CAMH reports   High levels of heavy metals found in China tobacco

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]